| Postsynaptic Densities (PSDs) | |
|---|---|
| Lineage | Neuronal compartment > Postsynaptic specialization |
| Markers | PSD95 (DLG4), NMDA receptor (GRIN1/2A), AMPA receptor (GRIA1/2), mGluR5, Shank3 |
| Brain Regions | Dendritic spines of excitatory neurons |
| Disease Vulnerability | [Alzheimer's Disease](/diseases/alzheimers-disease), Schizophrenia, Autism |
Postsynaptic Densities (PSDs) are specialized postsynaptic compartments found at excitatory synapses in the brain. They represent highly organized protein networks that orchestrate synaptic signaling, plasticity, and structural stability. PSDs are primarily located on dendritic spines of excitatory neurons and serve as the primary signaling hub for glutamatergic neurotransmission.
The PSD contains hundreds of proteins organized into layered zones: a membrane-associated guanylate kinase (MAGUK) scaffold centered on PSD95 organizes NMDA receptors and associated signaling molecules at the core, while AMPA receptors are positioned more peripherally. This organization enables precise temporal and spatial control of synaptic transmission.
Postsynaptic Densities (PSDs) are a specialized cell type classified within the Neuronal compartment > Postsynaptic specialization lineage. These cells are primarily found in Dendritic spines of excitatory neurons and are characterized by expression of marker genes including PSD95 (DLG4), NMDA receptor (GRIN1/2A), AMPA receptor (GRIA1/2), mGluR5. They are selectively vulnerable in Alzheimer's Disease, Schizophrenia, Autism.
The PSD consists of multiple protein families organized into functional modules:
Postsynaptic Densities (PSDs) are identified by the expression of the following key marker genes:
These markers are used for immunohistochemical identification and single-cell RNA sequencing classification, as catalogued in the Allen Cell Type Atlas.
Postsynaptic Densities (PSDs) play essential roles in neural circuits and brain function. They are found in the following brain regions:
Their normal functions include:
PSDs receive glutamatergic input and convert it into postsynaptic electrical and biochemical signals. The tight clustering of receptors ensures high-sensitivity detection of neurotransmitter release.
PSDs are central to learning and memory processes. Long-term potentiation (LTP) and long-term depression (LTD) involve dynamic remodeling of PSD composition, including:
The PSD links to the actin cytoskeleton via Shank proteins, maintaining dendritic spine morphology essential for proper synaptic connectivity.
Postsynaptic Densities (PSDs) show selective vulnerability in the following neurodegenerative conditions:
In AD, PSDs undergo significant alterations:
The amyloid-beta oligomers directly bind to NMDA receptors, causing internalization and disrupting synaptic plasticity mechanisms. Tau pathology also targets PSD components, leading to synaptic loss.
The selective vulnerability of these cells is an active area of research, with factors including metabolic demands, calcium handling, exposure to toxic protein aggregates, and cell-autonomous gene expression programs contributing to their susceptibility.
Single-cell and single-nucleus RNA sequencing studies have revealed the transcriptomic signature of Postsynaptic Densities (PSDs). Key differentially expressed genes from the Allen Cell Type Atlas and related datasets include the marker genes listed above. These transcriptomic profiles help identify subtypes and disease-associated gene expression changes.
The study of Postsynaptic Densities has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.